{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:09:33Z","timestamp":1759410573431,"version":"3.40.5"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["2016"],"award-info":[{"award-number":["2016"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["2015"],"award-info":[{"award-number":["2015"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Programa Nacional de Imuniza\u00e7\u00f5es","award":["277\/2013"],"award-info":[{"award-number":["277\/2013"]}]},{"name":"Secretaria de Vigil\u00e2ncia em Sa\u00fade","award":["2013-2017"],"award-info":[{"award-number":["2013-2017"]}]},{"name":"Bio-Manguinhos\/FIOCRUZ","award":["016\/2013"],"award-info":[{"award-number":["016\/2013"]}]},{"name":"PROEP\/CPqRR\/FIOCRUZ","award":["401998\/20126"],"award-info":[{"award-number":["401998\/20126"]}]},{"name":"PDTIS","award":["2013-2017"],"award-info":[{"award-number":["2013-2017"]}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","award":["2013-2107"],"award-info":[{"award-number":["2013-2107"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Immunological Methods"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.jim.2017.05.002","type":"journal-article","created":{"date-parts":[[2017,5,14]],"date-time":"2017-05-14T13:45:57Z","timestamp":1494769557000},"page":"9-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Heparin removal by ecteola-cellulose pre-treatment enables the use of plasma samples for accurate measurement of anti-Yellow fever virus neutralizing antibodies"],"prefix":"10.1016","volume":"448","author":[{"given":"Ana Carolina","family":"Campi-Azevedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa","family":"Peruhype-Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordana Grazziela","family":"Coelho-dos-Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Costa-Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Yoshida","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila Maria Barbosa de","family":"Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0063-7963","authenticated-orcid":false,"given":"Marisol","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernanda Magalh\u00e3es Freire","family":"Campos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline","family":"de Castro Zacche Tonini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elenice Moreira","family":"Lemos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo Cristiano","family":"Brum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana Guimar\u00e3es","family":"de Noronha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos Silva","family":"Freire","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria de Lourdes Sousa","family":"Maia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Ant\u00f4nio Bastos","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Rios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caren","family":"Chancey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla Magda","family":"Domingues","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9a","family":"Teixeira-Carvalho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olindo Assis","family":"Martins-Filho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jim.2017.05.002_bb0005","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/00001721-199308000-00016","article-title":"Enzymatic elimination of heparin from plasma for activated partial thromboplastin time and prothrombin time testing","volume":"4","author":"van den Besselaar","year":"1993","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.jim.2017.05.002_bb0010","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/ajcp\/71.6.665","article-title":"Prothrombin time after heparin removal. Application to monitoring simultaneous anticoagulation with heparin and coumarins","volume":"7","author":"Branson","year":"1979","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.jim.2017.05.002_bb0015","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nm0897-866","article-title":"Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate","volume":"3","author":"Chen","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.jim.2017.05.002_bb0020","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1128\/JVI.72.2.1577-1585.1998","article-title":"A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate","volume":"72","author":"Chung","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.jim.2017.05.002_bb0025","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0049-3848(86)90278-1","article-title":"In vitro neutralization of heparin in plasma prior to the activated partial thromboplastin time test: an assessment of four heparin antagonists and two anion exchange resins","volume":"1\u201341","author":"Cumming","year":"1986","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jim.2017.05.002_bb0030","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1055\/s-0038-1656035","article-title":"Modulation of blood cell activation by four commonly used anticoagulants","volume":"77","author":"Engstad","year":"1997","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jim.2017.05.002_bb0035","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1006\/mthe.2002.0578","article-title":"Cell surface heparan sulfate is a receptor for attachment of envelope protein-free retrovirus-like particles and VSV-G pseudotyped MLV-derived retrovirus vectors to target cells","volume":"5","author":"Guibinga","year":"2002","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jim.2017.05.002_bb0040","series-title":"Vaccinia Virus and Poxvirology: Methods and Protocols","first-page":"243","article-title":"Monitoring of human immunological responses to vaccinia virus","volume":"269","author":"Harrop","year":"2004"},{"key":"10.1016\/j.jim.2017.05.002_bb0045","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/039139889702000308","article-title":"The use of a heparin removal device: a valid alternative to protamine","volume":"20","author":"Hendrikx","year":"1997","journal-title":"Int. J. Artif. Organs"},{"key":"10.1016\/j.jim.2017.05.002_bb0050","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.virol.2014.06.039","article-title":"A highly specific monoclonal antibody against monkeypox virus detects the heparin binding domain of A27","volume":"464\u2013465","author":"Hughes","year":"2014","journal-title":"Virology"},{"issue":"9","key":"10.1016\/j.jim.2017.05.002_bb0055","article-title":"Dengue type four viruses with E-Glu345Lys adaptive mutation from MRC-5 cells induce low viremia but elicit potent neutralizing antibodies in rhesus monkeys","volume":"24","author":"Lin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jim.2017.05.002_bb0060","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.coi.2013.09.014","article-title":"A systems framework for vaccine design","volume":"25","author":"Mooney","year":"2013","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jim.2017.05.002_bb0065","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/COH.0b013e32834dc37b","article-title":"Systems vaccinology: its promise and challenge for HIV vaccine development","volume":"7","author":"Nakaya","year":"2012","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10.1016\/j.jim.2017.05.002_bb0070","first-page":"370","article-title":"Vaccinology in the era of high-throughput biology","volume":"19","author":"Nakaya","year":"2015","journal-title":"Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci."},{"key":"10.1016\/j.jim.2017.05.002_bb0075","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1046\/j.1365-3156.1999.00496.x","article-title":"Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA","volume":"4","author":"Niedrig","year":"1999","journal-title":"Tropical Med. Int. Health"},{"key":"10.1016\/j.jim.2017.05.002_bb0080","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nri2629","article-title":"Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology","volume":"9","author":"Pulendran","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"111","key":"10.1016\/j.jim.2017.05.002_bb0085","doi-asserted-by":"crossref","first-page":"12300","DOI":"10.1073\/pnas.1400476111","article-title":"Systems vaccinology: probing humanity's diverse immune systems with vaccines","volume":"26","author":"Pulendran","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jim.2017.05.002_bb0090","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/ni.1688","article-title":"Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans","volume":"10","author":"Querec","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jim.2017.05.002_bb0095","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/bio.2015.0026","article-title":"Optimized treatment of heparinized blood fractions to make them suitable for analysis","volume":"13","author":"S\u00e1nchez-Fito","year":"2015","journal-title":"Biopreserv. Biobanking"},{"key":"10.1016\/j.jim.2017.05.002_bb0100","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.biologicals.2012.09.005","article-title":"Evaluation of accuracy and reliability of the plaque reduction neutralization test (micro-PRNT) in detection of yellow fever virus antibodies","volume":"40","author":"Sim\u00f5es","year":"2012","journal-title":"Biologicals"},{"key":"10.1016\/j.jim.2017.05.002_bb0105","first-page":"922","article-title":"Removal of heparin and protamine from plasma","volume":"88","author":"Thompson","year":"1976","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.jim.2017.05.002_bb0110","doi-asserted-by":"crossref","DOI":"10.1111\/trf.13766","article-title":"Optimal conditions for the performance of a monocyte monolayer assay","author":"Tong","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.jim.2017.05.002_bb0115","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/cyto.a.22892","article-title":"Peripheral blood microvesicles secretion is influenced by storage time, temperature, and anticoagulants","volume":"89","author":"Wisgrill","year":"2016","journal-title":"Cytometry A"},{"key":"10.1016\/j.jim.2017.05.002_bb0120","series-title":"Specimen Collection and Processing: Sources of Biological Variation","first-page":"42","article-title":"Tietz textbook of clinical chemistry. 3","author":"Young","year":"1999"}],"container-title":["Journal of Immunological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175917300649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022175917300649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T18:53:00Z","timestamp":1656010380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022175917300649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":24,"alternative-id":["S0022175917300649"],"URL":"https:\/\/doi.org\/10.1016\/j.jim.2017.05.002","relation":{},"ISSN":["0022-1759"],"issn-type":[{"type":"print","value":"0022-1759"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heparin removal by ecteola-cellulose pre-treatment enables the use of plasma samples for accurate measurement of anti-Yellow fever virus neutralizing antibodies","name":"articletitle","label":"Article Title"},{"value":"Journal of Immunological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jim.2017.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}